Use of topical medication in orofacial neuropathic pain: a retrospective study

Gary Heir, Scott Karolchek, Mythili Kalladka, Archana Vishwanath, Julyana Gomes, Raashi Khatri, Cibele Nasri-Heir, Eli Eliav, Sowmya Ananthan

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objective: The objective of this study was to evaluate the effect of topical medications as a single treatment or in combination with systemic medications in the treatment of orofacial neuropathic pain conditions. Study design: A retrospective chart review of 39 patients treated for orofacial neuropathic pain at the Orofacial Pain Clinic in the New Jersey Dental School was performed. In line with the treatment selection, the subjects were divided into 3 groups: topical medications only (n = 12), systemic medications only (n = 10), and a combination of both (n = 17). Results: The starting pain level as expressed in pain Visual Analog Scale for the 3 groups was significantly different. The combined treatment group baseline pain level (7.5 ± 0.403 SEM; P = .0015) and the systemic treatment only group pain level (8.6 ± 0.611 SEM; P = .0375) was significantly elevated compared to the topical only group (6.1 ± 0.716 SEM; P = .1057). Following treatment, pain level was significantly reduced in all 3 groups. The combined group had the highest pain relief (52.0 ± 6.676 SEM % reduction; P < .0001) followed by the systemic-only group (40.6 ± 9.727 SEM % reduction; P = .0029) and the topicals-only group (40.9 ± 10.775 SEM% reduction; P = .0048). The time taken for the topical treatment only to act was significantly shorter (3 weeks ± 0.479 SEM; P = .0015) when compared with the systemic-only (4 weeks ± 0.772 SEM; P = .3629) and the combined group (5.5 weeks ± 0.912 SEM; P = .1738). Conclusion: Topical medication as single treatment or in combination with systemic medications can reduce orofacial neuropathic pain severity. Further prospective research should be performed to validate this treatment option.

Original languageEnglish (US)
Pages (from-to)466-469
Number of pages4
JournalOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology
Volume105
Issue number4
DOIs
StatePublished - Apr 1 2008

Fingerprint

Facial Pain
Neuralgia
Retrospective Studies
Pain
Therapeutics
Pain Clinics
Dental Schools
Pain Measurement
Patient Selection

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oral Surgery
  • Otorhinolaryngology
  • Dentistry(all)

Cite this

Heir, Gary ; Karolchek, Scott ; Kalladka, Mythili ; Vishwanath, Archana ; Gomes, Julyana ; Khatri, Raashi ; Nasri-Heir, Cibele ; Eliav, Eli ; Ananthan, Sowmya. / Use of topical medication in orofacial neuropathic pain : a retrospective study. In: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology. 2008 ; Vol. 105, No. 4. pp. 466-469.
@article{46b5b437c7534f68aa6b55094f762b4d,
title = "Use of topical medication in orofacial neuropathic pain: a retrospective study",
abstract = "Objective: The objective of this study was to evaluate the effect of topical medications as a single treatment or in combination with systemic medications in the treatment of orofacial neuropathic pain conditions. Study design: A retrospective chart review of 39 patients treated for orofacial neuropathic pain at the Orofacial Pain Clinic in the New Jersey Dental School was performed. In line with the treatment selection, the subjects were divided into 3 groups: topical medications only (n = 12), systemic medications only (n = 10), and a combination of both (n = 17). Results: The starting pain level as expressed in pain Visual Analog Scale for the 3 groups was significantly different. The combined treatment group baseline pain level (7.5 ± 0.403 SEM; P = .0015) and the systemic treatment only group pain level (8.6 ± 0.611 SEM; P = .0375) was significantly elevated compared to the topical only group (6.1 ± 0.716 SEM; P = .1057). Following treatment, pain level was significantly reduced in all 3 groups. The combined group had the highest pain relief (52.0 ± 6.676 SEM {\%} reduction; P < .0001) followed by the systemic-only group (40.6 ± 9.727 SEM {\%} reduction; P = .0029) and the topicals-only group (40.9 ± 10.775 SEM{\%} reduction; P = .0048). The time taken for the topical treatment only to act was significantly shorter (3 weeks ± 0.479 SEM; P = .0015) when compared with the systemic-only (4 weeks ± 0.772 SEM; P = .3629) and the combined group (5.5 weeks ± 0.912 SEM; P = .1738). Conclusion: Topical medication as single treatment or in combination with systemic medications can reduce orofacial neuropathic pain severity. Further prospective research should be performed to validate this treatment option.",
author = "Gary Heir and Scott Karolchek and Mythili Kalladka and Archana Vishwanath and Julyana Gomes and Raashi Khatri and Cibele Nasri-Heir and Eli Eliav and Sowmya Ananthan",
year = "2008",
month = "4",
day = "1",
doi = "10.1016/j.tripleo.2007.09.030",
language = "English (US)",
volume = "105",
pages = "466--469",
journal = "Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",
issn = "2212-4403",
publisher = "Elsevier USA",
number = "4",

}

Use of topical medication in orofacial neuropathic pain : a retrospective study. / Heir, Gary; Karolchek, Scott; Kalladka, Mythili; Vishwanath, Archana; Gomes, Julyana; Khatri, Raashi; Nasri-Heir, Cibele; Eliav, Eli; Ananthan, Sowmya.

In: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, Vol. 105, No. 4, 01.04.2008, p. 466-469.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Use of topical medication in orofacial neuropathic pain

T2 - a retrospective study

AU - Heir, Gary

AU - Karolchek, Scott

AU - Kalladka, Mythili

AU - Vishwanath, Archana

AU - Gomes, Julyana

AU - Khatri, Raashi

AU - Nasri-Heir, Cibele

AU - Eliav, Eli

AU - Ananthan, Sowmya

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Objective: The objective of this study was to evaluate the effect of topical medications as a single treatment or in combination with systemic medications in the treatment of orofacial neuropathic pain conditions. Study design: A retrospective chart review of 39 patients treated for orofacial neuropathic pain at the Orofacial Pain Clinic in the New Jersey Dental School was performed. In line with the treatment selection, the subjects were divided into 3 groups: topical medications only (n = 12), systemic medications only (n = 10), and a combination of both (n = 17). Results: The starting pain level as expressed in pain Visual Analog Scale for the 3 groups was significantly different. The combined treatment group baseline pain level (7.5 ± 0.403 SEM; P = .0015) and the systemic treatment only group pain level (8.6 ± 0.611 SEM; P = .0375) was significantly elevated compared to the topical only group (6.1 ± 0.716 SEM; P = .1057). Following treatment, pain level was significantly reduced in all 3 groups. The combined group had the highest pain relief (52.0 ± 6.676 SEM % reduction; P < .0001) followed by the systemic-only group (40.6 ± 9.727 SEM % reduction; P = .0029) and the topicals-only group (40.9 ± 10.775 SEM% reduction; P = .0048). The time taken for the topical treatment only to act was significantly shorter (3 weeks ± 0.479 SEM; P = .0015) when compared with the systemic-only (4 weeks ± 0.772 SEM; P = .3629) and the combined group (5.5 weeks ± 0.912 SEM; P = .1738). Conclusion: Topical medication as single treatment or in combination with systemic medications can reduce orofacial neuropathic pain severity. Further prospective research should be performed to validate this treatment option.

AB - Objective: The objective of this study was to evaluate the effect of topical medications as a single treatment or in combination with systemic medications in the treatment of orofacial neuropathic pain conditions. Study design: A retrospective chart review of 39 patients treated for orofacial neuropathic pain at the Orofacial Pain Clinic in the New Jersey Dental School was performed. In line with the treatment selection, the subjects were divided into 3 groups: topical medications only (n = 12), systemic medications only (n = 10), and a combination of both (n = 17). Results: The starting pain level as expressed in pain Visual Analog Scale for the 3 groups was significantly different. The combined treatment group baseline pain level (7.5 ± 0.403 SEM; P = .0015) and the systemic treatment only group pain level (8.6 ± 0.611 SEM; P = .0375) was significantly elevated compared to the topical only group (6.1 ± 0.716 SEM; P = .1057). Following treatment, pain level was significantly reduced in all 3 groups. The combined group had the highest pain relief (52.0 ± 6.676 SEM % reduction; P < .0001) followed by the systemic-only group (40.6 ± 9.727 SEM % reduction; P = .0029) and the topicals-only group (40.9 ± 10.775 SEM% reduction; P = .0048). The time taken for the topical treatment only to act was significantly shorter (3 weeks ± 0.479 SEM; P = .0015) when compared with the systemic-only (4 weeks ± 0.772 SEM; P = .3629) and the combined group (5.5 weeks ± 0.912 SEM; P = .1738). Conclusion: Topical medication as single treatment or in combination with systemic medications can reduce orofacial neuropathic pain severity. Further prospective research should be performed to validate this treatment option.

UR - http://www.scopus.com/inward/record.url?scp=40549117874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40549117874&partnerID=8YFLogxK

U2 - 10.1016/j.tripleo.2007.09.030

DO - 10.1016/j.tripleo.2007.09.030

M3 - Article

C2 - 18329583

AN - SCOPUS:40549117874

VL - 105

SP - 466

EP - 469

JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

SN - 2212-4403

IS - 4

ER -